Incyte reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Incyte announced earnings per share of $0.65 on revenue of $579.4M. Analysts polled by Investing.com anticipated EPS of $0.35 on revenue of $576.62M. That with comparison to EPS of $0.32 on revenue of $528.4M in the same period a year before. Incyte had reported EPS of $0.59 on revenue of $551.58M in the previous quarter. Analysts are expecting EPS of $0.31 and revenue of $550.49M in the upcoming quarter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,